标题
The Therapeutic Potential of Nanobodies
作者
关键词
-
出版物
BIODRUGS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-05
DOI
10.1007/s40259-019-00392-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
- (2019) Marie Scully et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of caplacizumab in a child with refractory thrombotic thrombocytopenic purpura
- (2019) Senthil Velan Bhoopalan et al. PEDIATRIC BLOOD & CANCER
- A randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin-17A/F Nanobody®, in moderate-to-severe psoriasis
- (2019) Danka Svecova et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Caplacizumab for relapsing thrombotic thrombocytopenic purpura
- (2019) Veronika Kaczmarek et al. PEDIATRIC NEPHROLOGY
- Exploiting Nanobodies’ Singular Traits
- (2018) Jessica R. Ingram et al. Annual Review of Immunology
- Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignancies
- (2018) Kasper Mølgaard et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An overview on the current status of cancer nanomedicines
- (2018) Nasimudeen R. Jabir et al. CURRENT MEDICAL RESEARCH AND OPINION
- Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects
- (2018) João C. Fernandes DRUG DISCOVERY TODAY
- Nanobody Based Dual Specific CARs
- (2018) Stijn De Munter et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nanoparticle crossing of blood–brain barrier: a road to new therapeutic approaches to central nervous system diseases
- (2018) Valentín Ceña et al. Nanomedicine
- Pharmacokinetic and pharmacodynamic modelling of the novel anti-ADAMTS-5 nanobody M6495 using the neo-epitope ARGS as a biomarker
- (2018) J. Pereira et al. OSTEOARTHRITIS AND CARTILAGE
- The anti-ADAMTS-5 nanobody ® , M6495, protects against cartilage breakdown in cartilage and synovial joint tissue explant models
- (2018) A. Siebuhr et al. OSTEOARTHRITIS AND CARTILAGE
- OUP accepted manuscript
- (2018) PROTEIN ENGINEERING DESIGN & SELECTION
- Comparative analysis of nanobody sequence and structure data
- (2018) Laura S. Mitchell et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- A HER2 bispecific antibody can be efficiently expressed in Escherichia�coli with potent cytotoxicity
- (2018) Limin Lin et al. Oncology Letters
- The structural basis of nanobody unfolding reversibility and thermoresistance
- (2018) Patrick Kunz et al. Scientific Reports
- Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
- (2018) Susan Hua et al. Frontiers in Pharmacology
- Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies
- (2018) Uroš Zavrtanik et al. JOURNAL OF MOLECULAR BIOLOGY
- Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier
- (2018) Danica B. Stanimirovic et al. BIODRUGS
- Tumor Microenvironment Targeted Nanotherapy
- (2018) Clara Fernandes et al. Frontiers in Pharmacology
- Endosomal trafficking regulates receptor-mediated transcytosis of antibodies across the blood brain barrier
- (2017) Arsalan S Haqqani et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura
- (2017) F. Peyvandi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Nanomaterial-Enabled Cancer Therapy
- (2017) Sabina Quader et al. MOLECULAR THERAPY
- Nanobodies® † †Nanobody is a registered trademark of Ablynx NV. as inhaled biotherapeutics for lung diseases
- (2017) Gino Van Heeke et al. PHARMACOLOGY & THERAPEUTICS
- BiHC, a T-Cell–Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells
- (2017) Jieyu Xing et al. Translational Oncology
- Tumor Microenvironment-Enabled Nanotherapy
- (2017) Liying Wang et al. Advanced Healthcare Materials
- Nanobody Technology: A Versatile Toolkit for Microscopic Imaging, Protein–Protein Interaction Analysis, and Protein Function Exploration
- (2017) Els Beghein et al. Frontiers in Immunology
- Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers
- (2017) Roghaye Arezumand et al. Frontiers in Immunology
- Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy
- (2017) Yaozhong Hu et al. Frontiers in Immunology
- Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
- (2017) Peter Bannas et al. Frontiers in Immunology
- A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
- (2017) Susann Albert et al. OncoImmunology
- The effect of tumour size on drug transport and uptake in 3-D tumour models reconstructed from magnetic resonance images
- (2017) Wenbo Zhan et al. PLoS One
- Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection
- (2016) Concepción Palomo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nanobodies as therapeutics: big opportunities for small antibodies
- (2016) Sophie Steeland et al. DRUG DISCOVERY TODAY
- Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases
- (2016) Cláudia Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
- (2016) Flora Peyvandi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- (2016) Daniel Bobo et al. PHARMACEUTICAL RESEARCH
- Strategies for transporting nanoparticles across the blood–brain barrier
- (2016) Tian-Tian Zhang et al. Biomaterials Science
- Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer
- (2016) Isabel Van Audenhove et al. EBioMedicine
- Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
- (2015) Jason M. Lajoie et al. Annual Review of Pharmacology and Toxicology
- Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
- (2015) Laurent Detalle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Production of Novel VHH Nanobody Inhibiting Angiogenesis by Targeting Binding Site of VEGF
- (2015) Walead Ebrahimizadeh et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- A novel nanobody specific for respiratory surfactant protein A has potential for lung targeting
- (2015) Huiping Li et al. International Journal of Nanomedicine
- Nanobodies as Probes for Protein Dynamicsin Vitroand in Cells
- (2015) Oleg Y. Dmitriev et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
- (2015) M. Keyaerts et al. JOURNAL OF NUCLEAR MEDICINE
- Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform
- (2015) Alex Klarenbeek et al. mAbs
- Nanobody-based cancer therapy of solid tumors
- (2015) Marta Kijanka et al. Nanomedicine
- Revisiting the Mechanisms of CNS Immune Privilege
- (2015) Antoine Louveau et al. TRENDS IN IMMUNOLOGY
- The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
- (2015) Maarten Van Roy et al. ARTHRITIS RESEARCH & THERAPY
- A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment
- (2014) Zahra Farajpour et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A novel platform for engineering blood-brain barrier-crossing bispecific biologics
- (2014) Graham K. Farrington et al. FASEB JOURNAL
- Bispecific T-cell engagers for cancer immunotherapy
- (2014) Amelia M Huehls et al. IMMUNOLOGY AND CELL BIOLOGY
- Targeted therapy using nanotechnology: focus on cancer
- (2014) Mario Sechi et al. International Journal of Nanomedicine
- Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
- (2014) Jens Niewoehner et al. NEURON
- A Human Blood-Brain Barrier Transcytosis Assay Reveals Antibody Transcytosis Influenced by pH-Dependent Receptor Binding
- (2014) Hadassah Sade et al. PLoS One
- Recent Advances in Nanooncology
- (2014) K. K. Jain TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Nanobodies as modulators of inflammation: potential applications for acute brain injury
- (2014) Björn Rissiek et al. Frontiers in Cellular Neuroscience
- Nanobody: The “Magic Bullet” for Molecular Imaging?
- (2014) Rubel Chakravarty et al. Theranostics
- New Applications of Nanotechnology for Neuroimaging
- (2013) G. Suffredini et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications
- (2013) Larissa Y Rizzo et al. CURRENT OPINION IN BIOTECHNOLOGY
- Camelid single-domain antibody-fragment engineering for (pre)clinicalin vivomolecular imaging applications: adjusting the bullet to its target
- (2013) Jens De Vos et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-Rotavirus Protein Reduces Stool Output in Infants With Diarrhea: A Randomized Placebo-Controlled Trial
- (2013) Shafiqul A. Sarker et al. GASTROENTEROLOGY
- Targeting tumors with nanobodies for cancer imaging and therapy
- (2013) Sabrina Oliveira et al. JOURNAL OF CONTROLLED RELEASE
- Nanotechnology in cancer therapy
- (2013) Burcu Aslan et al. JOURNAL OF DRUG TARGETING
- Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer
- (2013) C. Xavier et al. JOURNAL OF NUCLEAR MEDICINE
- Nanobodies and their potential applications
- (2013) Gholamreza Hassanzadeh-Ghassabeh et al. Nanomedicine
- Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications
- (2013) Malka Shilo et al. Nanoscale
- Challenges and Opportunities in Absorption, Distribution, Metabolism, and Excretion Studies of Therapeutic Biologics
- (2012) Xin Xu et al. AAPS Journal
- Nebulized Anti–IL-13 Monoclonal Antibody Fab′ Fragment Reduces Allergen-Induced Asthma
- (2012) Jonathan Hacha et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging
- (2012) Tengfei Li et al. FASEB JOURNAL
- Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancer
- (2012) Steve Schoonooghe et al. IMMUNOBIOLOGY
- Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
- (2012) Isil Altintas et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicines and Nanodiagnostics Come of Age
- (2012) Ijeoma F. Uchegbu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A mechanistic compartmental model for total antibody uptake in tumors
- (2012) Greg M. Thurber et al. JOURNAL OF THEORETICAL BIOLOGY
- Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
- (2012) M. J. W. D. Vosjan et al. MOLECULAR CANCER THERAPEUTICS
- Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody
- (2012) Marek Pruszynski et al. NUCLEAR MEDICINE AND BIOLOGY
- Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects
- (2012) J. A. J. M. van de Water et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific Cell Targeting with Nanobody Conjugated Branched Gold Nanoparticles for Photothermal Therapy
- (2011) Bieke Van de Broek et al. ACS Nano
- Advances in the field of nanooncology
- (2011) KK Jain BMC Medicine
- Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier
- (2011) G Caljon et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by PhiC31 integrase
- (2011) Farnoush Jafari Iri-Sofla et al. EXPERIMENTAL CELL RESEARCH
- A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
- (2011) Rob C. Roovers et al. INTERNATIONAL JOURNAL OF CANCER
- Dual Beneficial Effect of Interloop Disulfide Bond for Single Domain Antibody Fragments
- (2011) Jochen Govaert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nanobody — Shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting
- (2011) Marina Talelli et al. JOURNAL OF CONTROLLED RELEASE
- Clinical impact of serum proteins on drug delivery
- (2011) Felix Kratz et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment
- (2011) Roy van der Meel et al. JOURNAL OF CONTROLLED RELEASE
- Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood-Brain Barrier Integrity by a Gap Junction-Dependent Mechanism
- (2011) E. A. Eugenin et al. JOURNAL OF NEUROSCIENCE
- “Camel nanoantibody” is an efficient tool for research, diagnostics and therapy
- (2011) S. V. Tillib MOLECULAR BIOLOGY
- Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor
- (2011) Mahdi Behdani et al. MOLECULAR IMMUNOLOGY
- Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood–brain barrier
- (2011) K.S. Rutgers et al. NEUROSCIENCE
- The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors
- (2011) Agnès Maillet et al. PHARMACEUTICAL RESEARCH
- Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin
- (2010) Marina Talelli et al. BIOMATERIALS
- Clinical value of blocking IL-6 receptor
- (2010) Toru Mima et al. CURRENT OPINION IN RHEUMATOLOGY
- Nanobodies®: proficient tools in diagnostics
- (2010) Lieven Huang et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Downregulation of EGFR by a novel multivalent nanobody-liposome platform
- (2010) Sabrina Oliveira et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicine
- (2010) Betty Y.S. Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting nanoparticles to cancer
- (2010) M. Wang et al. PHARMACOLOGICAL RESEARCH
- Tumour-targeted nanomedicines: principles and practice
- (2008) T Lammers et al. BRITISH JOURNAL OF CANCER
- General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
- (2008) Cécile Vincke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nanomedicine: Application of Nanobiotechnology in Medical Practice
- (2008) K.K. Jain MEDICAL PRINCIPLES AND PRACTICE
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
- Factors determining antibody distribution in tumors
- (2008) G THURBER et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- New frontiers in nanotechnology for cancer treatment
- (2008) Frank Alexis et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Camelid immunoglobulins and nanobody technology
- (2008) S. Muyldermans et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started